2-구획 인공 모세혈관 모델을 이용한 Pseudomonas aeruginosa 임상균주에 대한 Panipenem의 효과

참고문헌 (28)

1. "Panipenem", betamipron, 2003, pp.63, 913~925
2. "Comparative in vitro activity of carbapenem antibiotics against respiratory pathogens isolated in recent years", 5, pp.171~175 (1999)
3. "Panipenem을 포함한 carbapenem 계열 항생제의 몇 가지 임상균주에 대한 시험관내 항균력", 35, pp.91~98 (2003)
4. "Antibacterial activity of panipenem", pp.3 1~13 (1991), a new carbapenem antibiotic
5. "Laboratory and clinical studies on panipenem", betamipron, 1991, pp.shige kusa(y n), 3 449~454
6. "CS-976(panipenem", betamipron)a new carbapenem antibiotic, 1991, pp.43, 1~73
7. "Recent developments in carbapenems", 11, pp.529~544 (2002)
8. "Overview of a new carbapenem,panipenem", betamipron, 1994, pp.20, 241~245
9. "Ion-exchange chromatography of amino acids in sweat collected from healthy subjects during sauna bathing", 20, pp.1305~1312 (1974)
10. "Performance standards for antimicrobial susceptibility testing; 12th informational supplement", pp.100~112 (2002)
11. "In vitro antibotic pharmacodynamic models, Antimicrobial pharmacodyanamics in theory and clinical practice", pp.41~65 (2002), Marcel Dekker, Inc.
12. "항균제의 약동학", 약력학, 1999, pp.17, 99~113
13. "시험관내 역동모델을 이용한 Klebsiella pneumoniae에 대한 ceftriaxone과 amikacin의 병용요법", 7, pp.40~48 (1999)
14. "Two compartment kinetic model with multiple artificial capillary units", 15, pp.131~137 (1985)
15. "Efficacies of vancomycin,arbekacin,and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model", 47, pp.3768~3773 (2003)
16. "Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model", 27, pp.343~349 (1985)
17. "Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae", 43, pp.79~86 (1999)
18. "Killing of Pseumomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model", 38, pp.931~936 (1994)
19. "Cefepime- aztreonam:a unique double β-lactam combination for Pseudomonas aeruginosa", 42, pp.1610~1619 (1998)
20. "Pharmacokinetics of panipenem", betamipron, 1991, pp.39, 227~235
21. "The use of antibiotics, a clinical review of antibacterial, antifungal and antiviral drugs 5th ed", pp.232~233 (1997), Butterworth-Heinemann
22. "Rapid bactericidal activities of carbapenems against Pseudomonas aeruginosa in simulating human plasma concentrations", 55, pp.187~195 (2002)
23. "Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media", 35, pp.529~532 (1991)
24. "In vitro antimicrobial activity of carbapenem antibiotics against Pseudomonas aeruginosa, measured using a low-concentration Mueller- Hinton Agar culture medium", 52, pp.449~457 (1999)
25. "Activity of the carbapenem panipenem and role of the OprD(D2)protein in its diffusion through the Pseudomonas aeruginosa outer membrane", 37, pp.322~327 (1993)
26. "Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants:role of outer membrane protein D2 in their diffusion", 25, pp.191~198 (1990)
27. "Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolates", 293, pp.191~197 (2003)
28. "C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem", 45, pp.1780~1787 (2001)

관련 논문AI추천